Please use this identifier to cite or link to this item:
Title: The role of the adaptive immune system in diabetic kidney disease (DKD).
Austin Authors: Kong, Lingyun;Andrikopoulos, Sofianos;MacIsaac, Richard;Mackay, Laura K;Nikolic-Paterson, David J;Torkamani, Niloufar ;Zafari, Neda;Marin, Evelyn C S;Ekinci, Elif I 
Affiliation: College of Sport and Exercise Science, Victoria University, Victoria, Australia
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia
Department of Nephrology, Monash Medical Centre and Monash University Centre for Inflammatory Diseases, Melbourne, Victoria, Australia
Endocrine Centre of Excellence
Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
Department of Endocrinology & Diabetes, St Vincent's Hospital Melbourne, Victoria, Australia
Issue Date: 30-Nov-2021
Date: 2021-11-30
Publication information: Journal of Diabetes Investigation 2021; online first: 30 November
Abstract: Diabetic kidney disease (DKD) is a highly prevalent complication of Diabetes Mellitus (DM) and the leading cause of end-stage kidney disease (ESKD). Inflammation is recognized as an important driver of progression of DKD. Activation of the immune response promotes a pro-inflammatory milieu and subsequently renal fibrosis and a progressive loss of renal function. While the role of the innate immune system in diabetic renal disease has been well characterised, the potential contribution of the adaptive immune system remains poorly defined. Emerging evidence in experimental models of DKD indicates an increase in the number of T cells in the circulation and in the kidney cortex, that in turn triggers secretion of inflammatory mediators such as IFN-γ and TNF-α, and activation of cells in innate immune response. In human studies, the number of T cells residing in the interstitial region of the kidney correlates with the degree of albuminuria in people with type 2 diabetes. Here, we review the role of the adaptive immune system, and associated cytokines, in the development of DKD. Furthermore, the potential therapeutic benefits of targeting the adaptive immune system as a means of preventing the progression of DKD will be discussed.
DOI: 10.1111/jdi.13725
ORCID: 0000-0001-8058-6977
Journal: Journal of Diabetes Investigation
PubMed URL: 34845863
Type: Journal Article
Subjects: Adaptive immune system
Diabetic kidney disease
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 12, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.